Kathryn Swanson in Conyers, Georgia

Home Georgia Conyers

Kathryn Swanson has Vascular Surgery as her primary medical specialty. Their primary office is: 1412 Milstead Ave Ne in Conyers, Georgia.

They're a part of the: Piedmont Cardiology Of Atlanta, Llc medical group which has around 390 members. You can call their office at 770-918-3000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Tulane University School Of Medicine and graduated in 2018 (around 6 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Kathryn Swanson Office Phone and Directions

Kathryn Swanson
Piedmont Cardiology Of Atlanta, Llc
1412 Milstead Ave Ne
Conyers, Georgia 30012
770-918-3000

Patient Ratings
Please rate your experience with Kathryn Swanson below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 770-918-3000

Enter a starting address:

Healthcare Info for Kathryn Swanson

Medical School: Tulane University School Of Medicine
Graduation Year: 2018
The Primary Medical Specialty for Kathryn Swanson is listed as: Vascular Surgery
Approximate Years of Experience: 6
PAC (PECOS ID)#: 9931456324
NPI #: 1427555986
NPI Created On: 04/11/2018
NPI Last Updated Listed as: 09/27/2023
Primary Taxonomy Code: 2086S0129X
License Number:
96912
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $39

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843901321

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Cardiology/Vascular Diseases

Name of Drug #1: ENHANCE Transcarotid Peripheral Access Kit

Drug or Biological: Device

Product Category #2: Cardiology/Vascular Diseases

Name Of Drug #2:: ENROUTE Transcarotid Neuroprotection System